Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Sees Significant Drop in Short Interest

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) was the recipient of a significant drop in short interest during the month of February. As of February 27th, there was short interest totaling 27,527,415 shares, a drop of 15.2% from the February 12th total of 32,453,225 shares. Approximately 30.4% of the company’s stock are short sold. Based on an average daily trading volume, of 3,871,657 shares, the days-to-cover ratio is currently 7.1 days. Based on an average daily trading volume, of 3,871,657 shares, the days-to-cover ratio is currently 7.1 days. Approximately 30.4% of the company’s stock are short sold.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Wellington Management Group LLP increased its stake in shares of Acadia Healthcare by 24.9% during the 4th quarter. Wellington Management Group LLP now owns 11,774,308 shares of the company’s stock worth $167,077,000 after purchasing an additional 2,350,760 shares during the last quarter. Vanguard Group Inc. lifted its stake in Acadia Healthcare by 7.8% in the third quarter. Vanguard Group Inc. now owns 9,417,045 shares of the company’s stock valued at $233,166,000 after purchasing an additional 681,278 shares during the last quarter. Goldman Sachs Group Inc. grew its holdings in Acadia Healthcare by 417.8% during the fourth quarter. Goldman Sachs Group Inc. now owns 4,728,613 shares of the company’s stock valued at $67,099,000 after purchasing an additional 3,815,471 shares during the period. Abrams Bison Investments LLC grew its holdings in Acadia Healthcare by 22.3% during the third quarter. Abrams Bison Investments LLC now owns 4,380,000 shares of the company’s stock valued at $108,449,000 after purchasing an additional 800,000 shares during the period. Finally, UBS Group AG increased its position in Acadia Healthcare by 8.8% in the third quarter. UBS Group AG now owns 4,336,698 shares of the company’s stock worth $107,377,000 after buying an additional 350,484 shares during the last quarter.

Acadia Healthcare Trading Down 3.1%

NASDAQ:ACHC opened at $22.79 on Tuesday. Acadia Healthcare has a 52 week low of $11.43 and a 52 week high of $31.04. The firm has a 50-day moving average price of $16.97 and a two-hundred day moving average price of $18.73. The company has a debt-to-equity ratio of 1.27, a quick ratio of 1.55 and a current ratio of 1.55. The firm has a market cap of $2.10 billion, a price-to-earnings ratio of -1.87, a price-to-earnings-growth ratio of 7.95 and a beta of 0.73.

Acadia Healthcare (NASDAQ:ACHC) last announced its earnings results on Wednesday, February 25th. The company reported $0.07 earnings per share for the quarter, topping analysts’ consensus estimates of $0.03 by $0.04. The firm had revenue of $821.46 million for the quarter, compared to the consensus estimate of $800.10 million. Acadia Healthcare had a positive return on equity of 6.53% and a negative net margin of 33.29%.The company’s revenue was up 6.1% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.64 EPS. Acadia Healthcare has set its FY 2026 guidance at 1.300-1.550 EPS and its Q1 2026 guidance at 0.250-0.300 EPS. On average, equities analysts expect that Acadia Healthcare will post 3.38 earnings per share for the current fiscal year.

Analyst Ratings Changes

ACHC has been the topic of a number of analyst reports. Cantor Fitzgerald set a $17.00 target price on shares of Acadia Healthcare in a report on Wednesday, December 3rd. Raymond James Financial reissued an “outperform” rating and set a $25.00 price objective on shares of Acadia Healthcare in a report on Thursday, February 26th. Zacks Research upgraded Acadia Healthcare from a “strong sell” rating to a “hold” rating in a report on Thursday, March 5th. Royal Bank Of Canada lifted their target price on Acadia Healthcare from $17.00 to $28.00 and gave the company an “outperform” rating in a research report on Thursday, February 26th. Finally, KeyCorp decreased their price target on Acadia Healthcare from $30.00 to $25.00 and set an “overweight” rating for the company in a report on Wednesday, December 3rd. Seven analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $21.15.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.